Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrk Us Inc Etf Regulatory News (INCE)

Share Price Information for Frk Us Inc Etf (INCE)

Share Price is delayed by 15 minutes
Get Live Data
10.25    0.006 (0.06%)
Bid:
10.222
Ask:
10.254
Spread: 0.032 (0.313%)
Market Cap: -
INCE Live PriceLast checked at - London Stock Exchange

Intraday Frk Us Inc Etf Share Chart

Cost rationalisation programme update

11 Oct 2022 07:00

RNS Number : 4084C
Ince Group PLC (The)
11 October 2022
 

 

 

 

11 October 2022

 

The Ince Group plc

("Ince", the "Company" or "Group")

 

Cost rationalisation programme update

 

The Ince Group plc (AIM: Ince), which provides legal, financial services, consulting, and pension advice services, announces that it has now implemented the annual cost savings of £4.0 million, identified in its announcement of 28 July 2022, as well as an additional approximately £1.0 million. This includes the recent agreement of a short term lease, lasting until April 2024, for a single floor office space at the Group's headquarters at Aldgate Tower.

 

These cost savings are incremental to the previously announced annual cost savings of £2.2 million that had been achieved prior to the recent fundraise. As a result, the Group has now taken action to reduce its annual run rate cost base in total by at least £7.2 million.

 

Donald Brown, Chief Executive Officer of The Ince Group plc, said: "This is another important step on our journey to rationalising the cost base of the Group to fit its true needs. New management has been successful in meeting our targets and has renewed our relationship with the landlord of Aldgate Tower and agreed a lease that allows us to focus on driving our core business forward at this important time without the added pressures of a full scale office relocation. I look forward to providing further updates on the business rationalisation and strategy we are implementing at the time of publication of our Annual Report."

 

Enquiries:

 

The Ince Group plc

Donald Brown, Chief Executive Officer

investorrelations@incegd.com

Simon Oakes, Chief Financial Officer

Allenby Capital Limited - Nominated Adviser

+44 (0) 20 3328 5656

Jeremy Porter / Piers Shimwell, Corporate Finance

Arden Partners plc - Broker

+44 (0) 20 7614 5900

John Llewellyn Lloyd, Corporate Finance

Louisa Waddell, Corporate Finance

Simon Johnson, Equity Sales

About The Ince Group plc

 

The Ince Group is a dynamic international legal and professional services business with offices in nine countries across Europe, Asia and the Middle East. With over 700 people, The Ince Group delivers legal advice, strategic guidance and business solutions to clients ranging from the world's oldest and biggest businesses operating across numerous industries to ultra-high net worth individuals. Through its entrepreneurial culture and "one firm" approach, the business offers its clients over 150 years of experience, insight and relationships. The Group is driven by a unique team of passionate people whose broad expertise and deep sector specialisms provide their clients with solutions to all their complex legal and strategic needs.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZMMGGGMGZZZ
Date   Source Headline
16th Jan 20097:00 amRNSTrading Statement
11th Nov 20087:00 amRNSTrading update
8th Oct 20085:05 pmRNSHolding(s) in Company
23rd Sep 20087:00 amRNSInterim Results
15th Sep 200810:50 amRNSHolding(s) in Company
15th Sep 200810:50 amRNSHolding(s) in Company
8th Sep 200810:13 amRNSHolding(s) in Company
11th Aug 20088:51 amRNSHolding(s) in Company
25th Jun 20087:00 amRNSHolding(s) in Company
10th Jun 20081:51 pmRNSResult of AGM
6th Jun 20084:32 pmRNSAnnual Report and Accounts
7th May 200812:09 pmRNSHolding(s) in Company
7th May 200812:08 pmRNSHolding(s) in Company
22nd Apr 20081:46 pmRNSHolding(s) in Company
15th Apr 200812:03 pmRNSHolding(s) in Company
12th Mar 20089:13 amRNSFinal Results - replacement
12th Mar 20087:00 amRNSFinal Results
29th Feb 200812:04 pmRNSTotal Voting Rights
15th Feb 20089:49 amRNSAdditional Listing
30th Jan 20087:01 amRNSAcquisition update
28th Jan 200812:48 pmRNSHolding(s) in Company
17th Jan 20087:01 amRNSPre-close Trading Update
31st Dec 20079:17 amRNSTotal Voting Rights
17th Dec 20074:31 pmRNSAdditional Listing
30th Nov 20079:05 amRNSTotal Voting Rights
13th Nov 200711:09 amRNSHolding(s) in Company
1st Nov 20073:09 pmRNSAdditional Listing
4th Oct 20073:40 pmRNSGrant of options
25th Sep 20077:04 amRNSDirectorate Change
25th Sep 20077:02 amRNSInterim Results
21st Aug 200712:49 pmRNSAIM Rule 26
30th Jul 200710:33 amRNSVoting Rights and Capital
25th Jul 200710:43 amRNSAdditional Listing
24th Jul 20072:32 pmRNSAdditional Listing
18th Jul 20077:00 amRNSTrading Statement
11th Jul 20075:04 pmRNSAdditional Listing
11th Jul 20073:51 pmRNSHolding(s) in Company
6th Jul 200711:49 amRNSAdditional Listing
29th Jun 200711:03 amRNSTotal Voting Rights
27th Jun 20072:20 pmRNSAdditional Listing
26th Jun 20073:28 pmRNSAdditional Listing
19th Jun 20074:37 pmRNSAdditional Listing
13th Jun 200712:14 pmRNSAGM Statement
31st May 200712:00 pmRNSTotal Voting Rights
11th May 200711:56 amRNSAdditional Listing
3rd May 20075:32 pmRNSHolding(s) in Company
1st May 20074:37 pmRNSAnnual Report and Accounts
30th Apr 20079:33 amRNSTotal Voting Rights
25th Apr 20073:36 pmRNSAdditional Listing
23rd Apr 20072:21 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.